Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

AstraZeneca PLC and Bristol-Myers Squibb Co Complete Acquisition of Rights for Byetta and Bydureon from Eli Lilly And Co


Monday, 1 Apr 2013 03:00am EDT 

AstraZeneca PLC and Bristol-Myers Squibb Co announced that they completed the acquisition of rights to Byetta (exenatide) and Bydureon (exenatide) from Eli Lilly And Co. AstraZeneca and Bristol-Myers Squibb started in January 2007 a diabetes alliance and a cooperation on research, development and sale for certain products for type 2 diabetes. 

Company Quote

51.51
0.39 +0.76%
19 Sep 2014